ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH EVAN YU
Management of mCRPC using Sipuleucel-T

VIEW ALL mCRPC VIDEOS

ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH JACOB BERCHUCK & MARY-ELLEN TAPLIN
Genetic Risk in Prostate Cancer

VIEW ALL PROSTATE CANCER VIDEOS

ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH KARIM FIZAZI
ARAMIS Trial in Prostate Cancer: Impact of Darolutamide on Pain and Quality of Life

VIEW ALL nmCRPC VIDEOS

EAU 2019 ANNUAL MEETING

EAU 2019 ANNUAL MEETING

INTERVIEW WITH THOMAS POWLES
Immunotherapy in the Peri-Operative Setting for Bladder Cancer

VIEW ALL BLADDER CANCER VIDEOS

Videos
State-of-the-industry video lectures by leading urology experts
Featured Videos

#AUA14 - Histologic analysis of tumor-parenchyma interface in patients with renal neoplasms - Session Highlights

ORLANDO, FL USA (UroToday.com) - The oncological propriety of enucleative or ‘minimal-margin’ partial nephrectomy (PN) close to the tumor edge remains debatable. The research group analyzed histo-pathologic data to objectively characterize the tumor-parenchyma interface as regards the tumor pseudo-capsule (PC), adjacent parenchyma, and intra-renal arteries.

auaThe study included a total of 124 partial or radical nephrectomy specimen slides. Best representative sections were selected. Intra-/extra-renal tumor surface was evaluated to document PC presence/absence, thickness and invasion. Under a 4X objective, 4 mm2 sectors were parceled out at 1, 2, 3, 4 and 5 mm distance from the tumor to evaluate: peri-tumoral inflammation, glomerulosclerosis (GS), arteriosclerosis (AS), nephrosclerosis (NS), and number/diameter of peri-tumor arterioles.

The median tumor size was 3.5 cm (0.7-18.5). One hundred seven tumors (90%) were malignant. Of the tumors, PC was present in 119 (96%). Median PC thickness was 0.6 mm (0.1-2.6). Intra-renal PC was identified in 82% of malignant and 31% of benign tumors (p < 0.0001). Presence of intra-renal PC correlated with clear cell RCC histology (p=0.0001). PC invasion was noted in 53 tumors, 51 (96%) of which were malignant (p < 0.04). No patient with PC invasion showed a positive surgical margin. Severity of parenchymal changes decreased with increasing distance from tumor margin: at 1 mm distance, moderate-to-severe inflammation, GS, AS and NS occurred in 38%, 20%, 17%, and 32% of patients, respectively; conversely, at 5 mm distance, mild inflammation, GS, AS and NS occurred in 2.5%, 0.8%, 4% and 0.8%, respectively (p < 0.0001). Mean arteriolar diameter decreased closer to the tumor: 0.7 mm diameter at 5 mm distance from the tumor, compared to 0.3 mm diameter at 1 mm distance (p < 0.0001).

The authors conclude that most renal cancers have a well-developed PC. Invasion of intra-renal PC occurs in up to a third of cancers. No patient with PC invasion had a positive surgical margin. The tumor-parenchyma interface is histologically altered, with increasing parenchymal changes (inflammation, GS, AS, NS) and decreasing arterial diameter closest to the tumor. In conclusion for PN surgery, the plane of dissection immediately adjacent to the tumor appears to be histologically safe, with the least chance of hemorrhage.

Presented by Raed A. Azhar, MD at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

Los Angeles, CA USA

Written by Achim Lusch, MD, University of California (Irvine), and medical writer for UroToday.com

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 4 Issue 1

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe